alt Hacker NewsThe big caveat, though, is access. These advances are still largely confined to high-income countries. Replicating this success globally is the next frontier
The big caveat, though, is access. These advances are still largely confined to high-income countries. Replicating this success globally is the next frontier
Practical speaking you are right. But the main ingredient in success is getting dosages and timing right, not ultra-expensive drugs.